Oncology medicines in Canada : trends and international comparisons, 2010-2019.: H82-51/2020E-PDF
"Oncology medicines are an increasingly important driver of Canadian pharmaceutical sales. Over the past decade, this significant segment has doubled its share of the market, now accounting for $3.9 billion in sales nationally. … This analysis provides an overview of the Canadian prescription oncology market from 2010 to 2019. The chartbook is divided into three sections: the first explores the dynamics of the international market for oncology medicines; the second takes a closer look at oncology sales, market distribution, and treatment costs in Canada; and the third examines these trends in the context of Canada's private drug plans"--Introduction, page 5.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.892097&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board, issuing body. |
|---|---|
| Title | Oncology medicines in Canada : trends and international comparisons, 2010-2019. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Les médicaments oncologiques au Canada : tendances et comparaisons internationales, 2010-2019. "October 2020." Issued also in HTML format. Includes bibliographical references. |
| Publishing information | Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2020. ©2020 |
| Description | 1 online resource (32 pages) : colour illustrations |
| ISBN | 9780660361628 |
| Catalogue number |
|
| Subject terms | Antineoplastic agents -- Canada -- Statistics. Antineoplastic agents -- Statistics. Antineoplastic agents -- Prices -- Canada -- Statistics. Antineoplastic agents -- Prices -- Statistics. |